WARNER CHILCOTT PLC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 9 rows in 2006. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2006-11-16: Reporting owner ANDRESS JAMES G; Form 3; Security Option to purchase Class A common shares; Transaction Holding.
- 2006-09-21: Reporting owner Cross Leland H; Form 4; Security Option to purchase Class A common shares; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2006-09-21: Reporting owner Hara Izumi; Form 4; Security Option to Purchase Class A common shares; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2006-09-21: Reporting owner Howard Alvin D; Form 4; Security Option to purchase Class A common shares; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2006-11-16 holding as of filing | ANDRESS JAMES G Director | 3 | Option to purchase Class A common shares Derivative · Direct | Holding | $13.19 exercise price | 2006-11-16 | ||
| 2006-09-21 | Cross Leland H Officer (Senior V.P., Tech. Operations) | 4 | Option to purchase Class A common shares Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +13,500 13,500 owned after | $15.00 exercise price | 2006-09-25 | |
| 2006-09-21 | Hara Izumi Officer (Sr. VP, Gen. Counsel & Sec.) | 4 | Option to Purchase Class A common shares Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,500 16,500 owned after | $15.00 exercise price | 2006-09-25 | |
| 2006-09-21 | Howard Alvin D Officer (Sr. V.P., Regulatory Affairs) | 4 | Option to purchase Class A common shares Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | −16,500 16,500 owned after | $15.00 exercise price | 2006-09-25 | |
| 2006-09-21 | Ellman Herman Officer (Senior V.P., Clinical Devel.) | 4 | Option to purchase Class A common shares Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +13,500 13,500 owned after | $15.00 exercise price | 2006-09-25 | |
| 2006-09-21 holding as of filing | Boissonneault Roger M Director, Officer (CEO & President) | 3 | Option to purchase Class A common shares Derivative · Direct | Holding | $22.98 exercise price | 2006-09-21 | ||
| 2006-09-21 holding as of filing | Herendeen Paul Officer (Exec. V.P. and CFO) | 3 | Option to purchase Class A common shares Derivative · Direct | Holding | $22.98 exercise price | 2006-09-21 | ||
| 2006-09-21 holding as of filing | Reichel W Carl Officer (President, Pharmaceuticals) | 3 | Option to purchase Class A common shares Derivative · Direct | Holding | $22.98 exercise price | 2006-09-21 | ||
| 2006-09-21 holding as of filing | Bruno Anthony D Officer (Exec. V.P., Corp. Development) | 3 | Option to purchase Class A common shares Derivative · Direct | Holding | $22.98 exercise price | 2006-09-21 |